Superior Institute of Biomedical Sciences, Ceara State University, Fortaleza, Ceara, Brazil.
J Sex Med. 2010 Nov;7(11):3610-9. doi: 10.1111/j.1743-6109.2009.01672.x.
Receptors for natriuretic peptides have been demonstrated as potential targets for the treatment of male erectile dysfunction.
This study investigates the relaxant effects of the atrial natriuretic peptide (ANP) and uroguanylin (UGN), and expression of natriuretic peptide receptors on strips of human corpora cavernosa (HCC).
Quantitative analysis of natriuretic receptor expression and relaxation of precontracted strips were used to assess the membrane-bound guanylate cyclase-cyclic guanosine monophosphate (cGMP) pathway in HCC strips.
HCC was obtained from a cadaver donor at the time of collection of organs for transplantation (14-47 years) and strips were mounted in organ baths for isometric studies.
ANP and UGN both induced concentration-dependent relaxation on HCC strips with a maximal response attained at 300 nM, corresponding to 45.4±4.0% and 49±4.8%, respectively. The relaxation is not affected by 30 µM 1H-[1,2,4]oxaolodiazolo[4,3-a]quinoxalin-1-one (ODQ) (a soluble guanylate cyclase inhibitor), but it is significantly blocked by 10 µM isatin, a nonspecific particulate guanylate cyclase (pGC) inhibitor. UGN was unable to potentiate electrical field stimulation (EFS) or acetylcholine-induced relaxations. The potential role of pGC activation and cGMP generation in this effect is reinforced by the potentiation of this effect by phosphodiesterase-5 inhibitor vardenafil (55.0±7.5-UGN vs. 98.6±1.4%-UGN+vardenafil; P<0.05). The relaxant effect was also partially (37.6%) blocked by the combination iberitoxin-apamin but was insensitive to glybenclamide. The expression of guanylate cyclase receptors (GC-A, GC-B, GC-C) and the expression of the natriuretic peptide "clearance" receptor (NPR-C) were confirmed by real-time polymerase chain reaction. The exposure of HCC strips to ANP (1 µM) and UGN (10 µM) significantly increased cGMP, but not cyclic adenosine monophosphate (cAMP) levels.
UGN relaxes HCC strips by a guanylate cyclase and K(ca)-channel-dependent mechanism. These findings obtained in HCC reveal that the natriuretic peptide receptors are potential targets for the development of new drugs for the treatment of erectile dysfunction.
已经证明,利钠肽受体是治疗男性勃起功能障碍的潜在靶点。
本研究旨在探讨心钠肽(ANP)和尿鸟苷素(UGN)对人海绵体组织(HCC)条带的松弛作用以及利钠肽受体的表达。
定量分析利钠肽受体表达和预收缩条带松弛,以评估 HCC 条带中环磷酸鸟苷(cGMP)途径的膜结合鸟苷酸环化酶。
在器官移植采集器官时,从尸体供体获得 HCC(14-47 岁),并将条带安装在器官浴中进行等长研究。
ANP 和 UGN 均诱导 HCC 条带浓度依赖性松弛,最大反应在 300 nM 时达到,分别对应 45.4±4.0%和 49±4.8%。松弛不受 30 µM 1H-[1,2,4]恶唑并[4,3-a]喹喔啉-1-酮(ODQ)(可溶性鸟苷酸环化酶抑制剂)的影响,但被 10 µM 靛红,一种非特异性颗粒鸟苷酸环化酶(pGC)抑制剂显著阻断。UGN 不能增强电刺激(EFS)或乙酰胆碱诱导的松弛。这种作用中 pGC 激活和 cGMP 生成的潜在作用通过磷酸二酯酶-5 抑制剂伐地那非增强这种作用得到加强(55.0±7.5-UGN 与 98.6±1.4%-UGN+伐地那非;P<0.05)。这种松弛作用也部分(37.6%)被伊贝替定-阿巴米阻断,但对格列本脲不敏感。通过实时聚合酶链反应证实了鸟苷酸环化酶受体(GC-A、GC-B、GC-C)和利钠肽“清除”受体(NPR-C)的表达。将 HCC 条带暴露于 ANP(1 µM)和 UGN(10 µM)可显著增加 cGMP,但不增加环磷酸腺苷(cAMP)水平。
UGN 通过鸟苷酸环化酶和钙通道依赖性机制松弛 HCC 条带。在 HCC 中获得的这些发现表明,利钠肽受体是开发治疗勃起功能障碍新药的潜在靶点。